Investigating post-transplant survival - Our research shows that CML patients who received a bone marrow transplant from an unrelated donor with matching tissue could expect about the same five-year survival rate as patients with matched related donors.
Understanding how treatment affects survivors – Research by Dr. Karen Syrjala shows that the decline in mental skills experienced by many bone marrow- and stem cell transplant patients is largely temporary. Patients who experience these symptoms can expect a return to normal cognitive function within a year of their transplant, and their mental conditions will continue improving. Learn more >
Studying survivors' long-term health – A study by Dr. Syrjala shows that, after 10 years, patients who received stem cell transplants for blood cancers are nearly as healthy as people who didn’t. Both populations had similar rates of asthma, diabetes, high blood pressure, high cholesterol and osteoporosis. In addition, they also had similar psychological health, marital satisfaction and employment. Learn more >